Navigation Links
Guggenheim Securities Expands Healthcare Equity Research Team
Date:8/14/2012

NEW YORK, Aug. 14, 2012 /PRNewswire/ -- Guggenheim Partners, LLC ("Guggenheim"), a global diversified financial services firm, today announced two appointments to its Equity Research team. Louise Chen, Managing Director, will cover the specialty pharmaceutical sector, and Bret Holley, Managing Director, will cover the biotechnology sector. Based in New York, both analysts will report to Raymond Katz, Director of Equity Research for Guggenheim Partners.

"We are excited to have two seasoned and talented analysts join our team. Guggenheim's growing equity research practice is strongly positioned to offer investors and the marketplace timely and informed analysis of the healthcare industry as it undergoes unprecedented change," said Mr. Katz.

Ms. Chen joins Guggenheim from New York-based firm Auriga USA LLC, where she was a Managing Partner and Senior Analyst of Equity Research. At Auriga, Ms. Chen covered small-to-mid cap specialty pharmaceutical companies such as Teva Pharmaceutical Industries, Forest Laboratories and Warner Chilcott. Prior to Auriga, she spent several years at investment bank Canaccord Genuity, where she led the coverage of 14 leading specialty pharmaceutical companies. Earlier in her career, Ms. Chen worked as a Vice President of Equity Research at Morgan Stanley and as a business development executive at Dr. Reddy's Laboratories.

Mr. Holley joins Guggenheim with more than 15 years of experience in the biotechnology sector.  He was most recently a Managing Director and Senior Research Analyst at Oppenheimer & Co., formerly CIBC World Markets, where  he spent more than a decade leading the coverage of some of the world's largest biotechnology companies, including Amgen Inc., Celgene Corp., Gilead Sciences and ImmunoGen, Inc. Earlier in his career, Mr. Holley was a bioinformatics application architect at Ingenuity Systems where he developed biotechnology data software and worked with major biotech and pharmaceutical companies.

About Guggenheim Partners
Guggenheim Partners, LLC is a privately held global financial services firm with more than $160 billion in assets under management. The firm provides asset management, investment banking and capital markets services, insurance, institutional finance and investment advisory solutions to institutions, governments and agencies, corporations, investment advisors, family offices and individuals. Guggenheim Partners is headquartered in New York and Chicago and serves clients around the world from more than 25 offices in nine countries. For more information about Guggenheim Partners, visit www.guggenheimpartners.com.

Contacts:
Torie von Alt
Guggenheim Partners
+1 212 378 6216
Torie.vonalt@guggenheimpartners.com

Or

Tripp Kyle / Mary Zimmerman
Brunswick Group
+1 212 333 3810
guggenheim@brunswickgroup.com


'/>"/>
SOURCE Guggenheim Partners, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hill-Rom to Participate in the Deutsche Bank Securities Health Care Conference
2. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
3. Omeros to Present at Deutsche Bank Securities Health Care Conference
4. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
5. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
6. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
7. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
8. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
9. ViroPharma To Participate In The JMP Securities Healthcare Conference
10. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
11. Uroplasty To Present At The JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016 France , Germany ... UK, and Israel ). It includes a 10-year epidemiology ... GD, segmented by age and sex in these markets. GD epidemiology report ... is in-depth, high quality, transparent and market-driven, providing expert analysis of disease ... Germany , Italy , Spain ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... to achieve significant growth as next generation systems ... and use radiology for cancer surgery. New systems ... radiological overdosing that has been such a problem ... be delivered. Radiosurgery robots take cancer surgery far ...
(Date:2/4/2016)... , Feb. 4, 2016 Summary ... common cancer and the most common cancer in women ... the disease exceedingly prevalent. The number of women diagnosed ... decades, but the number of deaths has declined due ... cancer treatment has been revolutionized in the past four ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD and Heather ... Napa Valley office. The technique utilizes the body’s own healing abilities to quickly ... Furnas, are part of only a select few cosmetic surgeons bringing this procedure ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... York (PRWEB) , ... February 05, 2016 , ... Regular ... and find themselves having to wait longer to access the treadmills. It’s a predictable ... Year’s resolutions to lose weight and get in shape by joining gyms, starting new ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... (APDA) announced the election of Patrick McDermott as Chairman of the National Board of ... welcome Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA ...
(Date:2/5/2016)... ... ... Colorize is a web theme package created exclusively for Final ... dynamic moving camera. Colorize is perfect for personal and web related videos and its ... to 5 focus points per scene, stage floor scene presets that are great for ...
Breaking Medicine News(10 mins):